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Cell adhesion molecules are critical to wound healing through leukocyte recruitment. Although P-selectin
glycoprotein ligand-1 (PSGL-1) regulates leukocyte rolling by binding P-selectin, but also binding E- and
L-selectins with lower affinity, little is known about a role of PSGL-1 in wound healing. To clarify a role of PSGL-1
and its interaction with E- and P-selectins in wound healing, we investigated cutaneous wound healing in PSGL-
1-deficient (PSGL-1/) mice in comparison with E-selectin/, P-selectin/, and P-selectin/ mice treated with
an anti-E-selectin antibody. PSGL-1 deficiency inhibited early wound healing, which was accompanied by
decreased inflammatory cell infiltration and growth factor expression. By contrast, E-selectin deficiency did not
affect wound healing. In general, the inhibitory effect of PSGL-1 deficiency on wound healing was similar to that
of P-selectin deficiency either alone or with E-selectin blockade. However, early granulation tissue formation,
late angiogenesis, and early infiltration of neutrophils and macrophages in PSGL-1/ mice were inhibited
beyond the inhibition in P-selectin/ mice, but to a similar level of inhibition in P-selectin/ mice with
E-selectin blockade. These results suggest that PSGL-1 contributes to wound healing predominantly as a
P-selectin ligand and partly as an E-selectin ligand by mediating infiltration of inflammatory cells.
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INTRODUCTION
The healing of cutaneous wounds consists of three phases,
namely: (1) an inflammatory phase, which consists of platelet
aggregation and the recruitment of inflammatory cells; (2) a
proliferative phase, which involves the migration and
proliferation of keratinocytes, fibroblasts, and endothelial
cells; and (3) a long remodeling phase (Singer and Clark,
1999; Werner and Grose, 2003). Skin wound healing is a
complex biological event as a result of the interplay of
resident and infiltrating cells, including neutrophils, macro-
phages, and mast cells (Gillitzer and Goebeler, 2001).
Infiltrating neutrophils form a first line of defense against
infection and are also a source of proinflammatory cytokines
(Hart, 2002). Macrophages also regulate wound healing by
antimicrobial function, wound debridement, and the produc-
tion of various growth factors, such as basic fibroblast growth
factor (bFGF), platelet-derived growth factor (PDGF), trans-
forming growth factor (TGF)-b, heparin-binding epidermal
growth factor, and TGF-a (Singer and Clark, 1999; Hart,
2002; Werner and Grose, 2003; Park and Barbul, 2004;
Tsirogianni et al., 2006). Mast cells are also considered an
important source of mediators during wound healing and are
detected at higher frequencies than in the non-injured skin
(Hebda et al., 1993; Trautmann et al., 2000). Thus, immune
cells play a critical role in the wound healing process.
The recruitment of immune cells into wound sites is a
multistep process that is highly regulated by multiple cell-
surface adhesion molecules (Ley et al., 2007). Leukocytes first
tether and roll on vascular endothelial cells, before they are
activated to adhere firmly and subsequently immigrate into
the extravascular space. The selectin family cooperates to
support leukocyte tethering and rolling along inflamed
vascular walls and consists of three cell-surface molecules
expressed by leukocytes (L-selectin), vascular endothelium
(E- and P-selectins), and platelets (P-selectin) (Ley and Kansas,
2004). P-selectin is rapidly expressed on the endothelial cell
surface upon degranulation of Weibel–Palade bodies, and its
synthesis can be further increased by cytokines (Petri et al.,
2008). E-selectin is expressed only after a delay, as it is
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upregulated by cytokines and requires de novo synthesis
(Petri et al., 2008). By contrast, L-selectin is constitutively
expressed on most leukocytes (Petri et al., 2008). Three
selectins have partially overlapping function for leukocyte
rolling (Robinson et al., 1999; Ley and Kansas, 2004).
P-selectin supports leukocyte rolling along postcapillary
venules at the earliest time of inflammation by interacting
with its ligand P-selectin glycoprotein ligand-1 (PSGL-1), a
mucin-like glycoprotein expressed by all subsets of leuko-
cytes (McEver and Cummings, 1997; Norman et al., 2000;
Ley and Kansas, 2004). PSGL-1 has been also shown to bind
E- and L-selectins, although their affinities are lower than
P-selectin (Asa et al., 1995; Sako et al., 1995; Guyer et al.,
1996; Yang et al., 1999a, b).
Earlier studies have shown critical roles of cell adhesion
molecules in wound healing (Subramaniam et al., 1997;
Nagaoka et al., 2000; Tsirogianni et al., 2006; Yukami et al.,
2007). The loss of intercellular adhesion molecule-1 (ICAM-1)
inhibits wound healing, whereas L-selectin deficiency alone
does not affect it (Nagaoka et al., 2000). However, the loss of
both L-selectin and ICAM-1 delays wound healing than that
of ICAM-1 alone, suggesting that L-selectin plays some roles
in the absence of ICAM-1 (Nagaoka et al., 2000). Similar to
L-selectin-deficient (L-selectin/) mice, E-selectin/ or
P-selectin/ mice exhibit normal wound healing (Subrama-
niam et al., 1997). However, combined E- and P-selectin
blockade or loss delays wound healing (Subramaniam et al.,
1997; Yukami et al., 2007). These results indicate that skin
wound healing is regulated cooperatively by selectins and
ICAM-1. However, a role of PSGL-1 in the wound-healing
process was not investigated earlier. Furthermore, in vitro and
in vivo studies have shown that PSGL-1 binds all selectins
with different affinities; however, the interaction of PSGL-1
with P- or E-selectin during wound healing remained
unknown. In this study, we examined the wound-healing
process using PSGL-1/ mice in comparison with E-
selectin/, P-selectin/, and P-selectin/ mice treated
with an anti-E-selectin mAb.
RESULTS
Macroscopic examination of wound healing
The areas of open wounds were measured 3 and 7 days after
wounding to assess macroscopic healing defects (Figures 1
and 2a). The areas of open wounds were similar between
wild-type and E-selectin/ mice on both days 3 and 7. On
day 3, the open wound area was larger in P-selectin/
(Po0.0001 and Po0.005), PSGL-1/ (Po0.0001 and
Po0.0001), and P-selectin/ mice administrated with anti-
E-selectin mAb (Po0.005 and Po0.05) than in wild-type and
E-selectin/ mice, respectively. However, on day 7, such
difference was no longer observed. There was no significant
difference between P-selectin/, PSGL-1/, and
P-selectin/ mice with E-selectin blockade on days 3 and
7. Therefore, the loss of PSGL-1 expression delayed macro-
scopic wound healing at the early time point, whereas
inhibitory effect of PSGL-1 deficiency was similar to that of P-
selectin deficiency either alone or with E-selectin blockade.
Microscopic examination of wound healing
Three microscopic parameters for wound healing were
evaluated, namely: (1) epithelial gap that is the distance
between the migrating edges of keratinocytes (Figure 2b); (2)
area of granulation tissue (Figure 2c); and (3) vessel density,
which represents angiogenesis (Figure 2d). On both days 3
and 7, E-selectin deficiency did not affect any of these
microscopic parameters. On day 3, P-selectin/ mice
showed larger epithelial gap and lower vessel density relative
to wild-type mice; there was no significant difference in the
epithelial gap and vessel density between P-selectin/,
PSGL-1/, and P-selectin/ mice with E-selectin blockade.
By contrast, on day 3, P-selectin/ mice had normal area of
granulation tissue; therefore, the area of granulation tissue
was significantly smaller in PSGL-1/ and P-selectin/
mice with E-selectin blockade than in P-selectin/ mice. On
day 7, the loss of P-selectin only decreased vessel density
Day 3 Day 7
Wild type
E-sel –/–
P-sel –/–
PSGL-1–/–
P-sel –/–
+anti-E
Figure 1. Macroscopic wound closure. Macroscopic wound closure in wild-
type, E-selectin (E-sel)/, P-selectin (P-sel)/, PSGL-1/, and P-sel/ mice
treated with an anti-E-selectin mAb (P-sel/þ anti-E) at 3 and 7 days after
wounding.Representative photographs of open wounds in wild-type and
mutant mice at 3 and 7 days after wounding are shown. Full-thickness
cutaneous wounds were made using a 6-mm biopsy punch.
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Figure 2. Macroscopic and microscopic wound healing parameters in wild-type, E-selectin (E-sel)/, P-selectin (P-sel)/, PSGL-1/, and P-sel/ mice treated
with an anti-E-selectin mAb (P-sel/þ anti-E) at 3 and 7 days after wounding. (a) The microscopic area of open wound was measured at 3 and 7 days after wounding
by tracing of the wound openings onto a transparency. The distance between the migrating edges of keratinocytes under the eschar (the epithelial gap; b) and
(c) the area of granulation tissue were both microscopically measured in the tissue sections. (d) Vessel density was microscopically measured in the whole wound bed
areas and was expressed as a percentage of the whole wound bed areas. All values represent the mean±SEM. These results were obtained from 14 mice in each group.
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relative to wild-type mice. However, when compared with
P-selectin/ mice, vessel density was significantly smaller in
PSGL-1/ and P-selectin/ mice with E-selectin blockade.
On day 3, PSGL-1/ and P-selectin/ mice with
E-selectin blockade exhibited larger epithelial gap, smaller
granulation tissue area, and lower vessel density compared
with wild-type mice; there was no significant deference
between these two groups. On day 7, such significant
difference remained for the granulation tissue area and vessel
density, but not for epithelial gap; similar to day 3, there was
no significant deference between these two groups. There-
fore, early granulation tissue formation and late angiogenesis
in PSGL-1/ mice were inhibited beyond the inhibition
associated with P-selectin deficiency, but to a similar level of
the inhibition observed in P-selectin/ mice with E-selectin
blockade.
Infiltration of inflammatory cells
Numbers of neutrophils that migrated outside the blood
vessels were assessed in the wound tissues by hematoxylin
and eosin (H&E) staining (Figures 3a and 4a). Neutrophils are
the first to appear in significant numbers immediately after
wounding, followed by macrophages. Furthermore, by day 1,
the large number of neutrophils precluded microscopic
quantitation. Therefore, we counted the neutrophil number
after early 1 and 4 hours. The loss of E-selectin expression did
not affect neutrophil numbers at 1 and 4 hours after
wounding. At 1 hour after wounding, neutrophil numbers
were reduced in P-selectin/, PSGL-1/, and P-selectin/
mice with E-selectin blockade relative to wild-type and
E-selectin/ mice. Furthermore, neutrophil numbers were
reduced in PSGL-1/ and P-selectin/ mice with E-selectin
blockade compared with P-selectin/ mice. Similar results
were obtained at 4 hours after injury.
Macrophage infiltration was assessed by immunohisto-
chemistry using anti-F4/80 mAb (Figures 3b and 4b).
Macrophage numbers were similar between E-selectin/
and wild-type mice on days 3 and 7. Similar to neutrophil
numbers, macrophage numbers decreased in P-selectin/,
PSGL-1/, and P-selectin/ mice with E-selectin blockade
relative to wild-type and E-selectin/ mice on day 3.
Moreover, macrophage numbers were lower in PSGL-1/
and P-selectin/ mice with E-selectin blockade than in
P-selectin/ mice. On day 7, such difference was no longer
detected.
Mast cell infiltration was assessed by toluidine blue
staining (Figures 3c and 4c). E-selectin deficiency did not
affect mast cell numbers on days 3 and 7. On day 3, mast cell
numbers were significantly reduced in P-selectin/,
PSGL-1/, and P-selectin/ mice with E-selectin blockade
relative to wild-type mice. Unlike neutrophil and macro-
phage numbers, there was no significant difference in mast
cell numbers between P-selectin/, PSGL-1/, and P-
selectin/ mice with E-selectin blockade. Similar results
were obtained on day 7, except that significant difference
between P-selectin/ and wild-type mice was no longer
observed. Thus, either P-selectin or PSGL-1 loss inhibited
early inflammatory responses until day 3, except for reduced
mast cell numbers in PSGL-1/ mice on day 7. Furthermore,
PSGL-1 deficiency inhibited early infiltration of neutrophils
and macrophages more strongly than P-selectin deficiency,
but to a similar level of P-selectin/ mice with E-selectin
blockade.
Growth factor mRNA expression in the wounded skin tissue
Expression of bFGF, IL-6, IL-10, TGF-b, PDGF, and tumor
necrosis factor (TNF)-amRNA in the wounded skin tissue was
examined by real-time reverse transcriptase-PCR (RT-PCR;
H&E staining
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Figure 3. Representative inflammatory cell recruitment in the wounded skin from wild-type, E-selectin (E-sel)/, P-selectin (P-sel)/, PSGL-1/, and
P-sel/ mice treated with anti-E-selectin mAb (P-sel/þ anti-E). (a) Neutrophils were detected in H&E-stained sections at 1 and 4 hours after wounding.
Arrows show representative neutrophils. Bars: 100mm. (b) Macrophages were detected in anti-F4/80 antibody-stained sections at 3 and 7 days after wounding.
Bars: 50mm. (c) Mast cells were detected in toluidine blue-stained sections at 3 and 7 days after wounding. Arrows show mast cells. Bars: 50 mm.
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Figure 5). There was no significant difference in all cytokines
examined in this study between E-selectin/ and wild-type
mice. By contrast, mRNA levels of all cytokines examined
in this study were significantly reduced in P-selectin/,
PSGL-1/, and P-selectin/ mice with E-selectin blockade
relative to wild-type mice on both days 3 and 7, except that
bFGF mRNA levels were similar between all groups on day 7.
There was no significant difference in all cytokines examined
in this study between P-selectin/, PSGL-1/, and
P-selectin/ mice with E-selectin blockade, except that
P-selectin/ mice with E-selectin blockade exhibited lower
IL-6 mRNA levels than P-selectin/ mice on day 3.
DISCUSSION
Loss or blockade of PSGL-1 reduces various inflammatory
conditions, such as ischemic reperfusion injury, peritonitis,
and vasculitis (Borges et al., 1997; Hayward et al., 1999;
Scalia et al., 1999; Yanaba et al., 2004). By contrast, PSGL-1 is
not required for the development of experimental autoimmune
encephalomyelitis (Engelhardt et al., 2005). Thus, contribution
1 hour600
400
200
0
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
Wild type E-sel−/− P-sel−/− PSGL-1−/− P-sel−/−
+anti-E
P<0.01 P<0.05 P<0.005 P<0.005
P<0.005
P<0.005
P <0.005
P<0.005P<0.005
P<0.05
P<0.005 P<0.005
P<0.005
P<0.005P<0.005
P<0.005 P<0.001
P<0.0001 P< 0.001
P<0.001P< 0.0001
P < 0.05 P <0.05
P <0.05 P<0.05
P <0.01 P<0.05 P<0.05
P<0.01 P<0.01
P<0.01
Ce
ll n
um
be
rs
/s
ec
tio
n
4 hours
Neutrophil numbers
1500
1000
500
0
Macrophage numbers
Day 3 Day 780
60
40
20
0
Ce
ll n
um
be
rs
/fi
el
d
100
80
60
40
20
0
Mast cell numbers
Day 3 Day 7150
100
50
0
150
100
50
0C
el
l n
um
be
rs
/s
ec
tio
n
Figure 4. Inflammatory cell recruitment in the wounded skin from wild-type, E-selectin (E-sel)/, P-selectin (P-sel)/, PSGL-1/, and P-sel/mice treated
with an anti-E-selectin mAb (P-sel/þ anti-E). (a) Numbers of neutrophils per section were counted in entire H&E-stained sections outside the blood
vessels under the microscope. (b) Numbers of anti-F4/80 Ab-positive macrophages per field (0.07mm2) were also counted. (c) Numbers of mast cells per section
were counted in entire toluidine blue-stained sections. All values represent the mean±SEM. These results were obtained from 10 mice in each group.
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of PSGL-1 to the inflammatory process varies according to the
tissue site of inflammation and/or the nature of the inflammatory
stimuli. In this study, PSGL-1 deficiency inhibited macroscopic
wound healing, keratinocyte migration, granulation tissue
formation, and angiogenesis on day 3. This inhibitory effect of
PSGL-1 loss on the early wound-healing process was associated
with reduced infiltration of neutrophils, macrophages, and mast
cells and decreased expression of various growth factors. In
contrast, macroscopic wound healing and the epithelial gap
were not affected by PSGL-1 loss on day 7, which could be
explained in part by normal macrophage infiltration and bFGF
expression on day 7, as macrophages is one of the important
sources for bFGF (Singer and Clark, 1999; Hart, 2002;
Tsirogianni et al., 2006). However, granulation tissue formation
and angiogenesis were inhibited by PSGL-1 deficiency on day
7, indicating that PSGL-1 also regulates granulation tissue
formation, especially angiogenesis, at the later time point. The
results of this study indicate that PSGL-1 regulates the wound-
healing process, especially early phase, by mediating infiltration
of inflammatory cells that produce various growth factors.
In vitro studies have shown that PSGL-1 binds P-selectin,
but also binds E- and L-selectins with lower affinity (Asa et al.,
1995; Sako et al., 1995; Guyer et al., 1996; Yang et al.,
1999a, b). An earlier study has revealed that L-selectin plays
minor roles during wound healing (Nagaoka et al., 2000).
However, in this study, would healing was suppressed in
PSGL-1/ mice to a similar level of P-selectin/ mice with
E-selectin blockade, suggesting that L-selectin may not
function as a PSGL-1 ligand during wound healing. Although
many studies have shown that the PSGL-1 and P-selectin
interaction is predominant (Sako et al., 1995; Yang et al.,
1999a, b), it is sill controversial whether PSGL-1 also interacts
with E-selectin. PSGL-1/ mice showed defects in
P-selectin-mediated, but not E-selectin-mediated rolling,
bringing the relevance of PSGL-1 as an E-selectin ligand into
question (Yang et al., 1999a, b). In contrast, another study has
revealed that the E-selectin–PSGL-1 interaction supports slow
rolling (Norman et al., 2000). Furthermore, a recent study
using another line of PSGL-1/ mice have shown that PSGL-1
has an important function in tethering flowing leukocytes to
E-selectin (Xia et al., 2002). In this study, there was generally
no significant difference in wound healing, leukocyte
accumulation, and growth factor expression between P-
selectin/ and PSGL-1/ mice, suggesting that the PSGL-1
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Figure 5. Growth factor mRNA expression in the wounded skin tissue from wild type mice, E-selectin (E-sel)/ mice, P-selectin (P-sel)/ mice, PSGL-1/
mice, and P-sel/ mice treated with anti-E-selectin mAb (P-sel/þ anti-E) at 3 and 7 days after wounding. Relative mRNA expression of IL-6, IL-10,
TNF-a, TGF-b, PDGF, and bFGF was quantified by real-time RT-PCR and normalized relative to endogenous GAPDH levels. All values represent the
mean±SEM. These results were obtained from 10 mice in each group.
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and P-selectin interaction is also predominant in wound
healing. However, early granulation tissue formation and late
angiogenesis in PSGL-1/ mice were inhibited beyond the
inhibition associated with P-selectin deficiency, but to a
similar level of the inhibition observed in P-selectin/ mice
with E-selectin blockade, suggesting that PSGL-1 may interact
with E-selectin in some aspects of wound healing. This is also
true of neutrophil and early macrophage infiltration. How-
ever, we did not examine wound healing using mice lacking
both P-selectin and E-selectin, as these mice are susceptible
to skin infection that could affect the wound healing (Bullard
et al., 1996; Frenette et al., 1996). Furthermore, no direct
functional or mechanistic results were presented in this study
to prove the direct interaction between PSGL-1 and E-
selectin. Nonetheless, the results of this study suggest that the
PSGL-1 and P-selectin interaction may primarily regulate the
wound-healing process, whereas E-selectin may also con-
tribute to some aspects of wound healing as a ligand of PSGL-1.
In this study, P-selectin/ mice exhibited impaired
wound healing and reduced infiltration of neutrophils,
macrophages, and mast cells, especially at the early phase.
However, an earlier study using P-selectin/ mice showed
no defects of wound healing with only reduced neutrophil
infiltration at 1 hour after wounding (Subramaniam et al.,
1997). This discrepancy may be due to the difference in the
genetic background: C57BL/6 background was used in this
study, whereas the mixed 129/svC57BL/6 background was
used in the earlier study. Many studies have shown that the
difference between C57BL/6 and mixed 129/svC57BL/6
background affects phenotypes of mice. For example, C1q/
mice have an increased susceptibility to nephrotoxic
nephritis, but this is seen on the mixed 129/svC57BL/6
background but not on C57BL/6 background (Robson et al.,
2003). These findings suggest that the 129/sv genetic back-
ground also affects the wound-healing process mediated by
P-selectin.
In this study, mRNA expressions of IL-6 IL-10, TNF-a,
TGF-b, and PDGF were reduced in P-selectin/, PSGL-1/,
and P-selectin/ mice with E-selectin blockade on day 7,
whereas only bFGF expression was normal in these mutant
mice. Nonetheless, macroscopic wound healing and kerati-
nocyte migration were not impaired in these mutant mice on
day 7, suggesting that bFGF plays the most important role in
wound healing. Consistent with this notion, application with
bFGF but not PDGF or TGF-b normalized the delayed wound
repair in mice lacking both L-selectin and ICAM-1 (Nagaoka
et al., 2000). In summary, the results of this study indicate
that PSGL-1 significantly regulates the early wound-healing
process by mediating early recruitment of leukocytes,
especially macrophages that produce various growth factors,
especially bFGF. Furthermore, our results suggest that PSGL-1
may function mainly as a P-selectin ligand and partly as an
E-selection ligand during wound healing.
MATERIALS AND METHODS
Mice
P-selectin/ (Frenette et al., 1996), E-selectin/ (Frenette et al.,
1996), and PSGL-1/ (Yang et al., 1999a, b) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). All mice were
healthy, fertile, and did not display evidence of infection or disease.
All mice were backcrossed between 5–10 generations onto the
C57BL/6 genetic background. Mice used for experiments were 7–12
weeks old. Age-matched wild-type littermates (Jackson Laboratory)
were used as controls. All mice were housed in a specific pathogen-
free barrier facility and screened regularly for pathogens. All studies
and procedures were approved by the Committee on Animal
Experimentation of Nagasaki University Graduate School of Biome-
dical Sciences.
Wounding and macroscopic examination
Mice were anesthetized with diethyl ether and their backs were
shaved and wiped with 70% alcohol. Full-thickness excisional
wounds were made by picking up a fold of skin and using a
disposable sterile 6-mm biopsy punch (Maruho, Osaka, Japan) to
punch through the two layers of skin on one flank, resulting in
generation of two wounds at the same time, as described
(Subramaniam et al., 1997). Similarly, two other wounds were
made on the other side of flank. After wounds were covered with
an occlusive dressing (3M Tegaderm, St. Paul, MN), mice were
caged individually. At 3 and 7 days after wounding, mice were
anesthetized, and the areas of open wounds were measured by
tracing the wound openings onto a transparency. Any signs
suggestive for local infection were not detected in the wounded
skin. After distorted wounds were excluded, one wound was
randomly selected in each mouse for the analysis. For macroscopic
analysis of wound closure, 14 mice were used in each group. For a
blocking study, mAbs to E-selectin (10E9.6, rat IgG2a, 30 mg per
mouse; BD PharMingen, San Diego, CA) (Bosse and Vestweber,
1994) were injected intravenously before wounding and on day 3.
This was the mAb concentration required to inhibit E-selectin-
dependent leukocyte rolling in vivo, as described earlier (Kunkel
et al., 1996).
Histological examination and immunohistochemistry
After the mice were killed, wounds were harvested with a 2-mm rim
of unwounded skin tissue. The wounds were cut into halves laterally;
one-half of the samples was fixed in 3.5% paraformaldehyde and
then paraffin embedded, and the remaining of each wound was
frozen with liquid nitrogen for mRNA analysis. Paraffin sections
(6mm) were stained with H&E, toluidine blue staining, or
immunostaining.
For immunostaining, deparafinized sections were treated with
endogenous peroxidase blocking reagent (DAKO Cytomation A/S,
Copenhagen, Denmark) and proteinase K (DAKO Cytomation A/S)
for 6minutes at room temperature. Sections were then incubated
with rat mAbs specific for macrophages (F4/80; American Type
Culture Collection, Rockville, MD). Rat IgG (Southern Biotechnol-
ogy Associates Inc., Birmingham, AI) was used as a control for
nonspecific staining. Sections were incubated sequentially with a
biotinylated rabbit anti-rat IgG as a secondary antibody (Vectastain
ABC method; Vector Laboratories, Burlingame, CA) and then
horseradish peroxidase-conjugated avidin-biotin complexes. Sections
were developed with 3,30-diaminobenzidine tetrahydrochloride and
hydrogen peroxide, and then counterstained with methyl green.
The number of neutrophils determined with H&E staining was
counted in the entire section outside the blood vessels at 1 and
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4hours after wounding. The number of mast cells was counted with
toluidine blue staining in the entire section at 3 and 7 days after
wounding. Numbers of F4/80-positive macrophages were deter-
mined by counting in nine high-power fields (0.07mm2, original
magnification,  400) in the wound bed per section. Among the
nine fields, six fields were selected from both edges of the wound
bed, and the remaining three fields were chosen from the middle of
it. For the analysis of neutrophils, macrophages, and mast cells, 10
mice were used in each group. The epithelial gap, which represents
distance between the leading edge of migrating keratinocytes, was
measured in H&E-stained sections of wounds. We identified the area
that consists of newly formed capillaries and the collection of
fibroblasts and macrophages as granulation tissue. Wound sections
were visualized by the color monitor (PVM-14M4J; OLYMPUS,
Tokyo, Japan) with the charge-coupled device camera (CS-900,
OLYMPUS). Then, the area of granulation tissue or vessel density
was gated and measured by the video micrometer system (VM-60;
OLYMPUS). Using the free-hand tool of Photoshop (Version 7.0,
Adobe systems, Tokyo, Japan), vessel density determined with H&E
staining was measured in the whole wound bed areas and was
expressed as a percentage of the whole wound bed areas. For
measurement of the epithelial gap, granulation tissue area, and
vessel density, 14 mice were used in each group.
RNA isolation and real-time RT-PCR
Total RNAs were extracted from frozen wounded skin samples using
Qiagen RNeasy spin columns (Qiagen, Crawley, UK) and subse-
quently were reverse-transcribed to cDNA using Ready-To-Go RT-
PCR Beads (GE Healthcare, Buckinghamshire, UK), according to the
manufacturer’s protocols. Real-time quantitative RT-PCR was
performed using the TaqMan system (Applied Biosystems, Foster
City, CA) on an ABI Prism 7300 Sequence Detector (Applied
Biosystems), according to the manufacturer’s instructions. TaqMan
probes and primers for bFGF, IL-6, IL-10, TGF-b1, PDGF, TNF-a,
and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were
purchased from Applied Biosystems. Relative expression of PCR
products was determined using the DDCT method. Briefly, each set of
samples was normalized using the difference in threshold cycle
(CT) between the target gene and housekeeping gene (GAPDH):
DCT¼ (CT target geneCTGAPDH). Relative mRNA levels were
calculated by the expression 2DDCT, where DDCT¼
DCT sampleDCT calibrator. Each sample was examined in duplicate
and the mean CT was used in the equation. For real-time RT-PCR
analysis of growth factor mRNA expression, 10 mice were used in
each group.
Statistical analysis
The Mann–Whitney test was used for determining the level of
significance of differences between samples and Bonferroni’s test
was used for multiple comparisons. A P-value o0.05 was
considered statistically significant.
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